Amgen drug combined with immunotherapy extends survival in lung cancer trial

Coverage, in order

1. 17d ago
   
   The Hindu Health India mainstream study

   Amgen drug combined with immunotherapy extends survival in lung cancer trial

   The Amgen drug is currently approved for adults in the advanced stages of small cell lung cancer that has worsened despite chemotherapy, based on data showing that Imdelltra reduced the risk of death by 40%

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.